-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On October 16, the National Medical Security Bureau issued the "Announcement on the Phased Results of Expert Review of Declared Drugs Adjusted by the National Medical Insurance Drug Catalogue in 2022 and Passed the Formal Review", in accordance with the "2022 National Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance Drug Catalogue Adjustment Work Plan", the National Medical Insurance Bureau organized experts to conduct a comprehensive review
of the declared drugs that passed the review of the adjustment form of the national basic medical insurance, work-related injury insurance and maternity insurance drug catalogue in 2022.
At present, the expert review has been completed
.
of the declared drugs that passed the review of the adjustment form of the national basic medical insurance, work-related injury insurance and maternity insurance drug catalogue in 2022.
At present, the expert review has been completed
.
All reporting enterprises can log on to the "2022 National Medical Insurance Drug Catalogue Adjustment Declaration" module of the national medical insurance service platform to query the expert review results
.
.
Drugs with evaluation results of "new to be added for negotiation" and "new to be added to be bid for bidding" indicate that the drug has been included in the negotiation and bidding scope of the 2022 national medical insurance drug catalogue and has obtained the qualification for negotiation and bidding, but it does not mean that the drug has been included in the 2022 national medical insurance drug catalogue
.
.
The National Medical Insurance Administration previously said that the adjustment of the medical insurance drug catalogue is divided into enterprise declaration, formal review, expert review, negotiation and bidding
.
At present, the expert review session is over, and it will soon enter the negotiation and bidding stage
.
Only by successfully passing all the links of catalog adjustment can it be finally included in the national medical insurance drug catalog
.
.
At present, the expert review session is over, and it will soon enter the negotiation and bidding stage
.
Only by successfully passing all the links of catalog adjustment can it be finally included in the national medical insurance drug catalog
.
If the progress goes well, the National Health Insurance Administration will publish a new version of the medical insurance drug catalogue in November, which will be implemented
on January 1 next year.
on January 1 next year.
